Lupus Innovation Award (LIA)
2024 Funded Grants
Alteration of epigenetic programs of HSPC underlies the chronic activation of innate cells in SLE
Franck Barrat, PhD
The Hospital for Special Surgery
PD-(L)1 checkpoint agonist therapies for lupus nephritis
Ross Dickins, PhD
Monash University
Investigating the role of IL-12 in Lupus
Rebecca Elsner, PhD
University of Pittsburgh
Better days ahead: Improving renal repair after LN flare
Nisha Limaye, PhD
de Duve Institute
Dysfunctional skin and bone loss in lupus
Theresa Lu, MD, PhD
The Hospital for Special Surgery
Anti-commensal bacteria reactivity of VH4-34-encoded IgG antibodies in SLE
Eric Meffre, PhD
Stanford University School of Medicine
Probing autoreactive T cells across tissues in SLE
Carolyn Moderbacher, PhD
La Jolla Institute For Immunology
“Failure to Appropriately Digest” as a new model of lupus pathogenesis
Justin Perry, PhD
Memorial Sloan Kettering Cancer Center
Multimodal Nanobody Immunotherapy for SLE
Novalia Pishesha, PhD
Boston Children's Hospital
Dysfunctional Tregs in lupus
Deepak Rao, MD, PhD
Brigham and Women's Hospital, Inc.
Piezo1 in Lupus Associated Cardiovascular Disease and Cognitive Impairment
Justin Van Beusecum, PhD
Medical University of South Carolina
2023 Funded Grants
Predicting response and non-response to therapy in SLE
Marta Alarcón-Riquelme, M.D., Ph.D.
Fundación Pública Andaluza Progreso Y Salud
Development of cell-based therapies targeting DNA-reactive B cells in SLE
Laura Belver, Ph.D.
Josep Carreras Leukaemia Research Institute
Identifying the mechanism of virus-induced lupus
Tarin Bigley, M.D., Ph.D.
Washington University, School of Medicine
Mechanisms for human TLR8 induced placental injury
Anne Davidson, MBBS
The Feinstein Institutes for Medical Research
Defining the determinants of lupus progression and cancerous transformation
Federico Gaiti, Ph.D.
University Health Network
Engineered immunological niche to monitor lupus nephritis
Aaron Morris, Ph.D.
The Regents of the University of Michigan
Systematic dissection of lupus non-coding risk variants in primary B cells
John Ray, Ph.D.
Benaroya Research Institute at Virginia Mason
Targeting anti-ERV B cells using CAAR T cells
Maria Tokuyama, Ph.D.
University of British Columbia
A multiomic approach to unravel immunology behind pregnancy complications in SLE
Lisa van Baarsen, Ph.D.
Amsterdam UMC
2022 Funded Grants
Vascular pathophysiology in CNS SLE: The blood-CSF barrier
Mark William DiFrancesco, PhD
Children’s Hospital Medical Center
Clinical applications of urine proteomics to lupus nephritis
Andrea Fava, MD
Johns Hopkins University School of Medicine
Noninvasive imaging of lupus nephritis disease activity
Eric Gale, PhD
Massachusetts General Hospital
Targeting autoreactive B cells to prevent thrombosis and fetal loss in SLE
Maximilian Ferdinand Konig, MD
Johns Hopkins University School of Medicine
Turning sweet on autoimmunity: impact of glycans in Systemic Lupus Erythematosus pathogenesis and treatment
Salomé S. Pinho, PhD
Instituto de Investigação e Inovação em Saúde
Acquired immunologic genetic variation in lupus pathogenesis and heterogeneity
Ansuman Satpathy, MD, PhD
Stanford University
Targeting VISTA in lupus skin disease and photosensitivity
Sladjana Skopelja-Gardner, PhD
Dartmouth College
2021 Funded Grants
Targeting the proteoglycan switch for lupus therapy
Nunzio Bottini, MD, PhD
Cedars-Sinai
Insights into lupus heterogeneity by single-cell profiling of B cell activation
Maria Gutierrez-Arcelus, PhD
Boston Children's Hospital
Targeting pathogenic endothelial dysfunction in lupus nephritis
James Oates, MD
Medical University of South Carolina
2020 Funded Grants
Multiplexed single-cell imaging in pediatric lupus nephritis
Elena Wen-Yuan Hsieh, MD
University of Colorado
2019 Funded Grants
Shining a light on the drivers of photosensitivity in systemic lupus
Michelle Kahlenberg, MD, PhD
University of Michigan